Humacyte Promotes Jeffrey Lawson to Chief Executive

Jeffrey Lawson has been appointed CEO of regenerative medicine company Humacyte. Lawson had been chief medical officer of the Research Triangle Park, NC, company since 2015. Lawson’s experience includes several roles at Duke University Medical Center. Former CEO Carrie Cox has taken on the role of executive chairman. Humacyte has developed a way to grow veins in a laboratory. The company is currently in Phase 3 studies testing these veins as an alternative to synthetic blood vessels for kidney failure patients.

Author: Frank Vinluan

Xconomy Editor Frank Vinluan is a business journalist with experience covering technology and life sciences. Based in Raleigh, he was a staff writer at the Triangle Business Journal covering technology, biotechnology and energy before joining MedCityNews.com as North Carolina bureau chief. Prior to moving to North Carolina’s Research Triangle in 2007 he held business reporting positions at The Des Moines Register and The Seattle Times.